$MVST
Microvast Holdings, Inc. Stock $mvst

$mvst Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000176068924000046 Filed on November 12, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$101.4M
YoY Change		26.55%
Cost Of Revenue		$67.78M
YoY Change		8.91%
Gross Profit		$33.61M
YoY Change		87.94%
Gross Profit Margin		33.15%
Selling, General & Admin		$16.80M
YoY Change		-46.54%
% of Gross Profit		49.99%
Research & Development		$10.69M
YoY Change		-19.25%
% of Gross Profit		31.81%
Depreciation & Amortization		$7.724M
YoY Change		53.38%
% of Gross Profit		22.98%
Operating Expenses		$27.51M
YoY Change		-38.43%
Operating Profit		$7.186M
YoY Change		-127.27%
Interest Expense		-$4.104M
YoY Change		-935.85%
% of Operating Profit		-57.11%
Other Income/Expense, Net		$7.399M
YoY Change		5725.98%
Pretax Income		$13.25M
YoY Change		-150.62%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings		$13.25M
YoY Change		-150.7%
Net Earnings / Revenue		13.07%
Basic Earnings Per Share		$0.04
Diluted Earnings Per Share		$0.03
COMMON SHARES
Basic Shares Outstanding	323.8M shares	323.8M shares
Diluted Shares Outstanding		367.0M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$63.59M
YoY Change		-31.55%
Cash & Equivalents		$63.59M
Short-Term Investments		$0.00
Other Short-Term Assets		$83.74M
YoY Change		75.77%
Inventory		$157.8M
Prepaid Expenses
Receivables		$121.5M
Other Receivables		$0.00
Total Short-Term Assets		$437.6M
YoY Change		8.33%
LONG-TERM ASSETS
Property, Plant & Equipment		$527.2M
YoY Change		-4.07%
Goodwill
YoY Change
Intangibles		$2.788M
YoY Change		-13.15%
Long-Term Investments
YoY Change
Other Assets		$11.09M
YoY Change		-61.14%
Total Long-Term Assets		$583.4M
YoY Change		-4.77%
TOTAL ASSETS
Total Short-Term Assets		$437.6M
Total Long-Term Assets		$583.4M
Total Assets		$1.021B
YoY Change		0.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$65.59M
YoY Change		-31.17%
Accrued Expenses		$23.36M
YoY Change		128.5%
Deferred Revenue		$42.95M
YoY Change		-21.17%
Short-Term Debt		$66.18M
YoY Change		166.65%
Long-Term Debt Due		$66.18M
YoY Change
Total Short-Term Liabilities		$335.9M
YoY Change		-0.15%
LONG-TERM LIABILITIES
Long-Term Debt		$121.0M
YoY Change		61.89%
Other Long-Term Liabilities		$38.49M
YoY Change		84.88%
Total Long-Term Liabilities		$38.49M
YoY Change		84.88%
TOTAL LIABILITIES
Total Short-Term Liabilities		$335.9M
Total Long-Term Liabilities		$38.49M
Total Liabilities		$511.8M
YoY Change		13.93%
SHAREHOLDERS EQUITY
Retained Earnings		-$987.5M
YoY Change		13.12%
Common Stock		$33.00K
YoY Change		3.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$509.2M
YoY Change
Total Liabilities & Shareholders Equity		$1.021B
YoY Change		0.44%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$13.25M
YoY Change		-150.7%
Depreciation, Depletion And Amortization		$7.724M
YoY Change		53.38%
Cash From Operating Activities		-$5.429M
YoY Change		-81.5%
INVESTING ACTIVITIES
Capital Expenditures		$14.18M
YoY Change		-76.34%
Acquisitions
YoY Change
Other Investing Activities		$9.650M
YoY Change		4208.04%
Cash From Investing Activities		-$4.530M
YoY Change		-92.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		18.15M
YoY Change		164.42%
NET CHANGE
Cash From Operating Activities		-$5.429M
Cash From Investing Activities		-4.530M
Cash From Financing Activities		18.15M
Net Change In Cash		-$5.429M
YoY Change		-93.4%
FREE CASH FLOW
Cash From Operating Activities		-$5.429M
Capital Expenditures		$14.18M
Free Cash Flow		-$19.61M
YoY Change		-78.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10692000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13241000	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4963000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6031000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	31824000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	25000000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address City Or Town EntityAddressCityOrTown	Stafford
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77477
	dei	City Area Code CityAreaCode	(281)
	dei	Local Phone Number LocalPhoneNumber	491-9505
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	323815298	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63585000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44541000	usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	40361000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	37477000	usd
CY2024Q3	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	5634000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3832000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4571000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	121539000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	188382000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	167839000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	33612000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	17884000	usd
	us-gaap	Gross Profit GrossProfit	78032000	usd
	us-gaap	Gross Profit GrossProfit	34203000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11841000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24980000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	59146000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	68874000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32291000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33609000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15580000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16916000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	313108457	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	317153113	shares
	dei	Document Type DocumentType	10-Q
	dei	Entity Address Address Line1 EntityAddressAddressLine1	12603 Southwest Freeway
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	509203000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	564190000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1021000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1096732000	usd
CY2024Q3	us-gaap	Revenues Revenues	101388000	usd
CY2023Q3	us-gaap	Revenues Revenues	80116000	usd
	us-gaap	Revenues Revenues	266414000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	67776000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	62232000	usd
CY2024Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	65000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	29911000	usd
CY2024Q3	mvst	Repayments Of Principal RepaymentsOfPrincipal	8375000	usd
CY2024Q3	mvst	Exchange Difference ExchangeDifference	3801000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	2093000	usd
CY2024Q3	mvst	Share Based Compensation Cost Of Sales ShareBasedCompensationCostOfSales	771000	usd
CY2023Q3	mvst	Share Based Compensation Cost Of Sales ShareBasedCompensationCostOfSales	1530000	usd
	mvst	Share Based Compensation Cost Of Sales ShareBasedCompensationCostOfSales	3390000	usd
	mvst	Share Based Compensation Cost Of Sales ShareBasedCompensationCostOfSales	4559000	usd
CY2024Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3392000	usd
CY2023Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	10444000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	19192000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	35031000	usd
CY2024Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1604000	usd
CY2023Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2953000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	5902000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	8660000	usd
CY2024Q3	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	534000	usd
CY2023Q3	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	935000	usd
	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	1805000	usd
	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	3391000	usd
CY2024Q3	mvst	Share Based Compensation Construction In Process ShareBasedCompensationConstructionInProcess	8000	usd
CY2023Q3	mvst	Share Based Compensation Construction In Process ShareBasedCompensationConstructionInProcess	140000	usd
	mvst	Share Based Compensation Construction In Process ShareBasedCompensationConstructionInProcess	22000	usd
	mvst	Share Based Compensation Construction In Process ShareBasedCompensationConstructionInProcess	429000	usd
CY2024Q3	mvst	Stock Based Compensation Total StockBasedCompensationTotal	6309000	usd
CY2023Q3	mvst	Stock Based Compensation Total StockBasedCompensationTotal	16002000	usd
	mvst	Stock Based Compensation Total StockBasedCompensationTotal	30311000	usd
	mvst	Stock Based Compensation Total StockBasedCompensationTotal	52070000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Profit Loss ProfitLoss	-81821000	usd
	mvst	Increase Decrease In Notes Payable IncreaseDecreaseInNotesPayable	-7490000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-197000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	515000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1374000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	138717000	usd
CY2024Q3	mvst	Note Receivables Net Current NoteReceivablesNetCurrent	10937000	usd
CY2023Q4	mvst	Note Receivables Net Current NoteReceivablesNetCurrent	23736000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	157769000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	149749000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	23483000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25752000	usd
	dei	Entity Registrant Name EntityRegistrantName	Microvast Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-38826
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-2530757
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2024Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	19897000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	437571000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	425606000	usd
CY2024Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	11021000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6171000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	527160000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	620667000	usd
CY2024Q3	mvst	Land Use Rights Net LandUseRightsNet	11902000	usd
CY2023Q4	mvst	Land Use Rights Net LandUseRightsNet	11984000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2788000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3136000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19468000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19507000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11090000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9661000	usd
CY2024Q3	us-gaap	Assets Assets	1021000000	usd
CY2023Q4	us-gaap	Assets Assets	1096732000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	65589000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	112618000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	56314000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	63374000	usd
CY2024Q3	mvst	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	104202000	usd
CY2023Q4	mvst	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	148284000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	42950000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	43087000	usd
CY2024Q3	mvst	Short Term Borrowings And Line Of Credit Current ShortTermBorrowingsAndLineOfCreditCurrent	66177000	usd
CY2023Q4	mvst	Short Term Borrowings And Line Of Credit Current ShortTermBorrowingsAndLineOfCreditCurrent	35392000	usd
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	656000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	655000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	335888000	usd
CY2024Q3	mvst	Long Term Bonds Payables LongTermBondsPayables	43157000	usd
CY2023Q4	mvst	Long Term Bonds Payables LongTermBondsPayables	43157000	usd
CY2024Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	53397000	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	43761000	usd
CY2024Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	1000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	67000	usd
CY2024Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	119000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	199000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16326000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17087000	usd
CY2024Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	24423000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38486000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	24861000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	511797000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	532542000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	323815298	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	316694442	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	322127798	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	315006942	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	33000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	32000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1512410000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1481241000	usd
CY2024Q3	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	6032000	usd
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	6032000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-987520000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21752000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25614000	usd
	us-gaap	Revenues Revenues	202042000	usd
CY2024Q3	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	12000	usd
CY2023Q3	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	422000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	64924000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	473000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	27508000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	44674000	usd
	us-gaap	Operating Expenses OperatingExpenses	171941000	usd
	us-gaap	Operating Expenses OperatingExpenses	119872000	usd
CY2024Q3	mvst	Subsidy Income SubsidyIncome	1082000	usd
CY2023Q3	mvst	Subsidy Income SubsidyIncome	442000	usd
	mvst	Subsidy Income SubsidyIncome	2351000	usd
	mvst	Subsidy Income SubsidyIncome	1156000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	7186000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-26348000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-91558000	usd
CY2024Q3	mvst	Interest Income InterestIncome	186000	usd
CY2023Q3	mvst	Interest Income InterestIncome	582000	usd
	mvst	Interest Income InterestIncome	551000	usd
	mvst	Interest Income InterestIncome	3481000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4290000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	491000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	8116000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1437000	usd
CY2024Q3	mvst	Gain On Change In Fair Value Of Warrant Liability And Convertible Note GainOnChangeInFairValueOfWarrantLiabilityAndConvertibleNote	2766000	usd
CY2023Q3	mvst	Gain On Change In Fair Value Of Warrant Liability And Convertible Note GainOnChangeInFairValueOfWarrantLiabilityAndConvertibleNote	-42000	usd
	mvst	Gain On Change In Fair Value Of Warrant Liability And Convertible Note GainOnChangeInFairValueOfWarrantLiabilityAndConvertibleNote	1240000	usd
	mvst	Gain On Change In Fair Value Of Warrant Liability And Convertible Note GainOnChangeInFairValueOfWarrantLiabilityAndConvertibleNote	-25000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7399000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	127000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7864000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	673000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13247000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26172000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-90019000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-81821000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	13247000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-26172000	usd
	us-gaap	Profit Loss ProfitLoss	-90019000	usd
	us-gaap	Profit Loss ProfitLoss	-81821000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-21000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	13247000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-26130000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-90019000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-81800000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	309541499	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	313108457	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	309541499	shares
CY2024Q3	us-gaap	Profit Loss ProfitLoss	13247000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-26172000	usd
	us-gaap	Profit Loss ProfitLoss	-90019000	usd
	us-gaap	Profit Loss ProfitLoss	-81821000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	11473000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2192000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3862000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-18006000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-28364000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-86157000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-99827000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-54000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-183000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24720000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28310000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-86157000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-99644000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	202042000	usd
	mvst	Revenue Related To Contracts Balance RevenueRelatedToContractsBalance	4208000	usd
	mvst	Revenue Related To Contracts Balance RevenueRelatedToContractsBalance	2485000	usd
CY2022Q4	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	4407000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-237000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1038000	usd
	mvst	Accounts Receivable Write Off AccountsReceivableWriteOff	531000	usd
	mvst	Accounts Receivable Write Off AccountsReceivableWriteOff	66000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	121000	usd
	mvst	Accounts Receivable Exchange Difference AccountsReceivableExchangeDifference	29000	usd
	mvst	Accounts Receivable Exchange Difference AccountsReceivableExchangeDifference	-182000	usd
CY2024Q3	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	3832000	usd
CY2023Q3	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	3242000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	3032000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	928000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	13738000	usd
CY2024Q3	mvst	Payables For Purchase Of Property Plant And Equipment PayablesForPurchaseOfPropertyPlantAndEquipment	54318000	usd
CY2023Q4	mvst	Payables For Purchase Of Property Plant And Equipment PayablesForPurchaseOfPropertyPlantAndEquipment	96350000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	18112000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14312000	usd
CY2024Q3	mvst	Accrued Payroll And Welfare AccruedPayrollAndWelfare	4445000	usd
CY2023Q4	mvst	Accrued Payroll And Welfare AccruedPayrollAndWelfare	8089000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	6118000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	6224000	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1429000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	41000	usd
CY2024Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	8415000	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	7117000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3214000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2413000	usd
CY2024Q3	mvst	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	104202000	usd
CY2023Q4	mvst	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	148284000	usd
CY2024Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	34184000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	37108000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	35217000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	42060000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	4024000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	3567000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	10353000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	9017000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	3970000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	7125000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	10516000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	15635000	usd
CY2024Q3	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-1216000	usd
CY2023Q3	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	202000	usd
	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-400000	usd
CY2024Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	35454000	usd
CY2023Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	33348000	usd
CY2024Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	35454000	usd
CY2023Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	33348000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	8151000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	13738000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	27303000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	21479000	usd
CY2024Q3	mvst	Product Warranty Total ProductWarrantyTotal	35454000	usd
CY2023Q4	mvst	Product Warranty Total ProductWarrantyTotal	35217000	usd
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	100000000	cny
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	383000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001760689
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	403410000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-897501000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-84513000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-42000	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	320545388	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	367031181	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	317153113	shares
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	24720000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	579717000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-26172000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15985000	usd
CY2023Q3	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-2192000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	567338000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	612977000	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2174000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52014000	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-18006000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	567338000	usd
	us-gaap	Profit Loss ProfitLoss	-90019000	usd
	us-gaap	Profit Loss ProfitLoss	-81821000	usd
	mvst	Gain Loss On Disposal Of Property Plant And Equipment GainLossOnDisposalOfPropertyPlantAndEquipment	810000	usd
	mvst	Gain Loss On Disposal Of Property Plant And Equipment GainLossOnDisposalOfPropertyPlantAndEquipment	832000	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	2248000	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	0	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	22442000	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	14643000	usd
	mvst	Amortization Of Land Use Right And Intangible Assets AmortizationOfLandUseRightAndIntangibleAssets	581000	usd
	mvst	Amortization Of Land Use Right And Intangible Assets AmortizationOfLandUseRightAndIntangibleAssets	593000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2004000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2108000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	30289000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	51641000	usd
	mvst	Gain On Change In Fair Value Of Warrant Liability And Convertible Note GainOnChangeInFairValueOfWarrantLiabilityAndConvertibleNote	1240000	usd
	mvst	Gain On Change In Fair Value Of Warrant Liability And Convertible Note GainOnChangeInFairValueOfWarrantLiabilityAndConvertibleNote	-25000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-237000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1038000	usd
	mvst	Provision For Obsolete Inventories ProvisionForObsoleteInventories	3032000	usd
	mvst	Provision For Obsolete Inventories ProvisionForObsoleteInventories	928000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	64924000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	473000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	10353000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	9017000	usd
	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	-9162000	usd
	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	22372000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-18157000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	911000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4144000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	54473000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2340000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12666000	usd
	mvst	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	1821000	usd
	mvst	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	5588000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-9037000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	653000	usd
	mvst	Increase Decrease In Notes Payable IncreaseDecreaseInNotesPayable	-26070000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-47234000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	53400000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-33094000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-869000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	2760000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	7679000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-319000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3287000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-70350000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27366000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	153574000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	425000	usd
	mvst	Proceeds On Disposal Of Property Plant And Equipment ProceedsOnDisposalOfPropertyPlantAndEquipment	9830000	usd
	mvst	Proceeds On Disposal Of Property Plant And Equipment ProceedsOnDisposalOfPropertyPlantAndEquipment	879000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5564000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11972000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-153120000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	70373000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	18439000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	6286000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	525000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	mvst	Deferred Payment Related To Purchases Of Property Plant And Equipment DeferredPaymentRelatedToPurchasesOfPropertyPlantAndEquipment	16389000	usd
	mvst	Deferred Payment Related To Purchases Of Property Plant And Equipment DeferredPaymentRelatedToPurchasesOfPropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	46635000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12153000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4598000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2088000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	26778000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-213405000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	88189000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	302617000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	114967000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	89212000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63585000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67398000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	51382000	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	21814000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114967000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89212000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	59408000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	75781000	usd
	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Microvast, Inc. was incorporated under the laws of the State of Texas in the United States of America on October 12, 2006 and re-domiciled to the State of Delaware on December 31, 2015. On July 23, 2021 (the “Closing Date”), Microvast, Inc. and Tuscan Holdings Corp.(“Tuscan”) consummated the previously announced merger (the “Merger” or the "Business Combination"), pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) dated February 1, 2021, between Tuscan, Microvast, Inc. and TSCN Merger Sub Inc., a Delaware corporation (“Merger Sub”).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the Merger Agreement, the Merger Sub merged with and into Microvast, Inc., with Microvast, Inc. surviving the Merger. As a result of the Merger, Tuscan was renamed “Microvast Holdings, Inc.” (the “Company”). The Merger was accounted for as a reverse recapitalization as Microvast, Inc. was determined to be the accounting acquirer under Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company and its subsidiaries (collectively, the “Group”) are primarily engaged in developing, manufacturing, and selling lithium-ion battery systems and components for electric vehicles and energy storage across the globe.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant accounting estimates reflected in the Group’s financial statements include allowance for credit losses, write-down of obsolete inventories, impairment of long-lived assets, valuation allowance for deferred tax assets, product warranty, fair value measurement of warrant liability, fair value measurement of convertible loan and share based compensation.</span></div>
CY2024Q3	us-gaap	Revenues Revenues	101388000	usd
CY2023Q3	us-gaap	Revenues Revenues	80116000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	33612000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	17884000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	13247000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-26172000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5429000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29342000	usd
	us-gaap	Revenues Revenues	266414000	usd
	us-gaap	Revenues Revenues	202042000	usd
	us-gaap	Gross Profit GrossProfit	78032000	usd
	us-gaap	Gross Profit GrossProfit	34203000	usd
	us-gaap	Profit Loss ProfitLoss	-90019000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	64924000	usd
	us-gaap	Profit Loss ProfitLoss	-81821000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3287000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-70350000	usd
CY2024Q3	mvst	Working Capital WorkingCapital	101683000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	509203000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-987520000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63585000	usd
CY2024Q3	mvst	Bank Borrowings Ending Balance BankBorrowingsEndingBalance	119574000	usd
CY2024Q3	mvst	Short Term Borrowings And Line Of Credit Current ShortTermBorrowingsAndLineOfCreditCurrent	66177000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	269711000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	29911000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	101388000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	80116000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	266414000	usd
CY2024Q3	mvst	Revenue Related To Contracts Balance RevenueRelatedToContractsBalance	883000	usd
CY2023Q3	mvst	Revenue Related To Contracts Balance RevenueRelatedToContractsBalance	1191000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19468000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	19540000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3214000	usd
CY2024Q3	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	12000	usd
CY2023Q3	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	422000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	64924000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	473000	usd
CY2024Q3	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	7709000	usd
CY2024Q3	mvst	Gain Loss On Convertible Debt And Warrants GainLossOnConvertibleDebtAndWarrants	2764000	usd
	mvst	Gain Loss On Convertible Debt And Warrants GainLossOnConvertibleDebtAndWarrants	1174000	usd
CY2024Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	125371000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	143288000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3832000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4571000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	121539000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	138717000	usd
CY2024Q2	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	4679000	usd
CY2023Q2	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	3468000	usd
CY2023Q4	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	4571000	usd
CY2024Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-992000	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-206000	usd
CY2024Q3	mvst	Accounts Receivable Write Off AccountsReceivableWriteOff	2000	usd
CY2023Q3	mvst	Accounts Receivable Write Off AccountsReceivableWriteOff	0	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2024Q3	mvst	Accounts Receivable Exchange Difference AccountsReceivableExchangeDifference	147000	usd
CY2023Q3	mvst	Accounts Receivable Exchange Difference AccountsReceivableExchangeDifference	-20000	usd
CY2024Q3	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	3832000	usd
CY2023Q3	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	3242000	usd
CY2024Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	102443000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	86379000	usd
CY2024Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36704000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	35867000	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	18622000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	27503000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	157769000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	149749000	usd
CY2024Q3	us-gaap	Inventory Write Down InventoryWriteDown	1295000	usd
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2024Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	8151000	usd
	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	2094000	usd
CY2023Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	475000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	65000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1503000	usd
CY2024Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	94237000	usd
CY2023Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	49146000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	79153000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	46395000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	9207000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	70373000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	18439000	usd
CY2023Q3	mvst	Repayments Of Principal RepaymentsOfPrincipal	2347000	usd
	mvst	Repayments Of Principal RepaymentsOfPrincipal	31824000	usd
	mvst	Repayments Of Principal RepaymentsOfPrincipal	6286000	usd
CY2023Q3	mvst	Exchange Difference ExchangeDifference	-349000	usd
	mvst	Exchange Difference ExchangeDifference	1872000	usd
	mvst	Exchange Difference ExchangeDifference	-2891000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	119574000	usd
CY2023Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	55657000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	119574000	usd
CY2023Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	55657000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	66177000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	35392000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	53397000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	43761000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	119574000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	79153000	usd
CY2024Q3	mvst	Pledged Buildings PledgedBuildings	121302000	usd
CY2023Q4	mvst	Pledged Buildings PledgedBuildings	124565000	usd
CY2024Q3	mvst	Pledged Machinery And Equipment PledgedMachineryAndEquipment	65091000	usd
CY2023Q4	mvst	Pledged Machinery And Equipment PledgedMachineryAndEquipment	0	usd
CY2024Q3	mvst	Pledged Land Use Rights PledgedLandUseRights	11902000	usd
CY2023Q4	mvst	Pledged Land Use Rights PledgedLandUseRights	11984000	usd
CY2024Q3	mvst	Pledged Construction In Progress PledgedConstructionInProgress	348000	usd
CY2023Q4	mvst	Pledged Construction In Progress PledgedConstructionInProgress	0	usd
CY2024Q3	mvst	Pledged Total Asset PledgedTotalAsset	198643000	usd
CY2023Q4	mvst	Pledged Total Asset PledgedTotalAsset	136549000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	27303000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	21479000	usd
CY2024Q3	mvst	Deferred Subsidy Income Noncurrent DeferredSubsidyIncomeNoncurrent	6093000	usd
CY2023Q4	mvst	Deferred Subsidy Income Noncurrent DeferredSubsidyIncomeNoncurrent	3382000	usd
CY2024Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	5090000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	0	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38486000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	24861000	usd
CY2024Q3	mvst	Long Term Bonds Payable LongTermBondsPayable	43157000	usd
CY2023Q4	mvst	Long Term Bonds Payable LongTermBondsPayable	43157000	usd
CY2018Q4	mvst	Bond Loan BondLoan	87776000	usd
CY2018Q4	mvst	Bond Loan BondLoan	600000000	cny
CY2018Q4	mvst	Equity Holding Pledged Percentage EquityHoldingPledgedPercentage	0.1239
	mvst	Debt Instrument Convertible Amount Subsidiary Value Threshold DebtInstrumentConvertibleAmountSubsidiaryValueThreshold	950000000	usd
	mvst	Supplement Agreements Entered Into SupplementAgreementsEnteredInto	2	agreement
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	14629000	usd
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	100000000	cny
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	14630000	usd
CY2024Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12
CY2024Q3	mvst	Debt Instrument Of Subscribed Amount DebtInstrumentOfSubscribedAmount	43157000	usd
CY2024Q3	mvst	Debt Instrument Of Subscribed Amount DebtInstrumentOfSubscribedAmount	295000000	cny
CY2021Q3	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	27600000	shares
CY2021Q3	mvst	Class Of Warrant Or Right Exercisable Period ClassOfWarrantOrRightExercisablePeriod	P30D
CY2021Q3	mvst	Warrant Term WarrantTerm	P5Y
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	63585000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	51382000	usd
CY2024Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	114967000	usd
CY2024Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	1000	usd
CY2024Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	24423000	usd
CY2024Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	24424000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	44541000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	43648000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	88189000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	67000	usd
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	67000	usd
	mvst	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Interest Paid FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInterestPaid	347000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	883000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2602000	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	79000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y3M18D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.052
	us-gaap	Operating Lease Payments OperatingLeasePayments	2518000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2258000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1347000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3781000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2917000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2458000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1873000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1681000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	10227000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	24284000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4744000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	19540000	usd
CY2021Q3	us-gaap	Standby Bond Purchase Commitment Expiration Period StandbyBondPurchaseCommitmentExpirationPeriod	P10Y
CY2021Q3	mvst	Exchange Ratio ExchangeRatio	160.3
CY2021Q3	mvst	Common Stock Reserved For Esop Plan CommonStockReservedForESOPPlan	0.05
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	32876682	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.01
CY2023Q4	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.73
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1521350	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.60
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.18
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31355332	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.08
CY2024Q3	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.80
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	31355332	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.08
CY2024Q3	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Expected To Vest And Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueExpectedToVestAndExercisable	4.80
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	30088665	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.14
CY2024Q3	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	4.89
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36091071	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.08
CY2022Q4	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.80
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	640000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.77
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	895706	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.02
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.64
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	35835365	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.03
CY2023Q3	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.76
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M6D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	35835365	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.03
CY2023Q3	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Expected To Vest And Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueExpectedToVestAndExercisable	4.76
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y7M6D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	23916879	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.14
CY2023Q3	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	4.90
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	856000	usd
	us-gaap	Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1 NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1	P0Y1M6D
CY2024Q3	mvst	Aggregate Intrinsic Value Of The Share Options AggregateIntrinsicValueOfTheShareOptions	0	usd
CY2024Q3	mvst	Gain Loss On Convertible Debt And Warrants GainLossOnConvertibleDebtAndWarrants	2764000	usd
	mvst	Gain Loss On Convertible Debt And Warrants GainLossOnConvertibleDebtAndWarrants	1174000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13247000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26130000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-90019000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-81800000	usd
CY2024Q3	mvst	Gain Loss On Fair Value Of Convertible Note GainLossOnFairValueOfConvertibleNote	-2764000	usd
CY2023Q3	mvst	Gain Loss On Fair Value Of Convertible Note GainLossOnFairValueOfConvertibleNote	0	usd
	mvst	Gain Loss On Fair Value Of Convertible Note GainLossOnFairValueOfConvertibleNote	0	usd
	mvst	Gain Loss On Fair Value Of Convertible Note GainLossOnFairValueOfConvertibleNote	0	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	10483000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-26130000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-90019000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-81800000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	320545388	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	313108457	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	317153113	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	309541499	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1048846	shares
CY2024Q3	mvst	Incremental Common Shares Attributable To Dilutive Effect Of Capped Nonvested Shares IncrementalCommonSharesAttributableToDilutiveEffectOfCappedNonvestedShares	1654338	shares
CY2024Q3	mvst	Incremental Common Shares Attributable To Dilutive Effect Of Convertible Loan IncrementalCommonSharesAttributableToDilutiveEffectOfConvertibleLoan	43782609	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	367031181	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	313108457	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	317153113	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	309541499	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	3	action
CY2024Q3	mvst	Liens Amount LiensAmount	35656000	usd
CY2024Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	4346000	usd

Files In Submission

Name	View Source	Status
0001760689-24-000046-index-headers.html	Edgar Link	pending
0001760689-24-000046-index.html	Edgar Link	pending
0001760689-24-000046.txt	Edgar Link	pending
0001760689-24-000046-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mvst-20240930.htm	Edgar Link	pending
mvst-20240930.xsd	Edgar Link	pending
mvst20240930-ex311.htm	Edgar Link	pending
mvst20240930-ex312.htm	Edgar Link	pending
mvst20240930-ex321.htm	Edgar Link	pending
mvst20240930-ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mvst-20240930_cal.xml	Edgar Link	unprocessable
mvst-20240930_def.xml	Edgar Link	unprocessable
mvst-20240930_lab.xml	Edgar Link	unprocessable
mvst-20240930_pre.xml	Edgar Link	unprocessable
mvst-20240930_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MVST
Microvast Holdings, Inc. Stock $mvst

2024 Q4 Form 10-Q Financial Statement

#000176068924000046 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MVST Microvast Holdings, Inc. Stock $mvst

2024 Q4 Form 10-Q Financial Statement

#000176068924000046 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MVST
Microvast Holdings, Inc. Stock $mvst